Ironwood Pharmaceuticals Inc 's Cash & cash equivalent grew by 9.16 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Ironwood Pharmaceuticals Inc 's Quick Ratio to 2.49, Quick Ratio remained below Ironwood Pharmaceuticals inc average.

Within Major Pharmaceutical Preparations industry 264 other companies have achieved higher Quick Ratio than Ironwood Pharmaceuticals Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 1129, from total ranking in the second quarter 2026 at 1867.

Explain Quick Ratio?
How much Cash & cash equivalents IRWD�s has?
What are IRWD�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/IRWD/financial-strength

https://api.csimarket.com/api/v1/companies/IRWD/fundamentals

https://api.csimarket.com/api/v1/companies/IRWD/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

IRWD Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-85.68 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-38.48 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	2.49	Subscribe	Subscribe	Subscribe	Subscribe
IRWD's Total Ranking	# 1129	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	5.72 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	9.16 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 265
Healthcare Sector	# 451
Overall Market	# 1129

Quick Ratio Statistics
High	Average	Low
31.05	5.44	0.33
(Mar 31 2023)		(Dec 31 2023)

Financial Statements
Ironwood Pharmaceuticals Inc 's Current Liabilities	$ 35 Millions	Visit IRWD's Balance sheet
Ironwood Pharmaceuticals Inc 's Cash & cash equivalent	$ 86 Millions	Visit IRWD's Balance sheet
Source of IRWD's Sales		Visit IRWD's Sales by Geography

Cumulative Ironwood Pharmaceuticals Inc 's Quick Ratio

IRWD's Quick Ratio for the trailling 12 Months

IRWD Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-2.66 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	39.77 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	1.1	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 1636	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-27.53 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-8.24 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to IRWD Financial Strength Comparisons >> Go to Compare IRWD Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Ironwood Pharmaceuticals Inc 's average Cash & cash equivalent, this led to increase in in Ironwood Pharmaceuticals Inc 's Quick Ratio to 1.1, Quick Ratio remained below IRWD average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 436 other companies have achieved higher Quick Ratio than Ironwood Pharmaceuticals Inc . While Quick Ratio overall ranking has improved so far to 3982, from total ranking during the twelve months ending second quarter 2026 at 4045.

Explain Quick Ratio?
How much Cash & cash equivalents IRWD�s has?
What are IRWD�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 437
Healthcare Sector	# 893
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
24.8	3.28	0.45
(Mar 31 2023)		(Mar 31 2024)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Major Pharmaceutical Preparations Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Nuvation Bio Inc	6.73	$ 663.370 Millions	$ 98.559 Millions
Ensysce Biosciences Inc	6.71	$ 29.671 Millions	$ 4.419 Millions
Anaptysbio Inc	6.71	$ 230.319 Millions	$ 34.318 Millions
Coya Therapeutics Inc	6.64	$ 35.802 Millions	$ 5.395 Millions
Capricor Therapeutics inc	6.61	$ 197.581 Millions	$ 29.895 Millions
Arcturus Therapeutics Holdings Inc	6.52	$ 184.817 Millions	$ 28.345 Millions
Moonlake Immunotherapeutics	6.50	$ 379.704 Millions	$ 58.430 Millions
Kiora Pharmaceuticals Inc	6.47	$ 16.287 Millions	$ 2.519 Millions
Camp4 Therapeutics Corporation	6.27	$ 124.522 Millions	$ 19.865 Millions
Context Therapeutics Inc	6.26	$ 34.411 Millions	$ 5.501 Millions
Sagimet Biosciences inc	6.22	$ 236.397 Millions	$ 37.985 Millions
Bridgebio Oncology Therapeutics Inc	6.18	$ 315.331 Millions	$ 51.026 Millions
Cartesian Therapeutics Inc	6.12	$ 122.975 Millions	$ 20.088 Millions
Olema Pharmaceuticals Inc	5.98	$ 413.771 Millions	$ 69.233 Millions
Summit Therapeutics Inc	5.71	$ 629.899 Millions	$ 110.226 Millions
Nurix Therapeutics Inc	5.51	$ 720.458 Millions	$ 130.742 Millions
United Therapeutics Corporation	5.51	$ 3,439.800 Millions	$ 624.300 Millions
Immuneering Corporation	5.45	$ 58.776 Millions	$ 10.791 Millions
Talphera Inc	5.29	$ 24.508 Millions	$ 4.630 Millions
Rocket Pharmaceuticals Inc	5.22	$ 279.470 Millions	$ 53.508 Millions
Aquestive Therapeutics Inc	5.22	$ 90.349 Millions	$ 17.299 Millions
Sionna Therapeutics Inc	5.11	$ 83.878 Millions	$ 16.420 Millions
Gain Therapeutics inc	4.94	$ 11.698 Millions	$ 2.369 Millions
Rani Therapeutics Holdings Inc	4.91	$ 45.288 Millions	$ 9.223 Millions
Abeona Therapeutics Inc	4.87	$ 134.941 Millions	$ 27.707 Millions
Shattuck Labs Inc	4.84	$ 61.758 Millions	$ 12.758 Millions
Mereo Biopharma Group Plc	4.75	$ 26.097 Millions	$ 5.494 Millions
Spruce Biosciences Inc	4.69	$ 87.691 Millions	$ 18.710 Millions
Diamedica Therapeutics Inc	4.68	$ 34.905 Millions	$ 7.454 Millions
Eledon Pharmaceuticals Inc	4.61	$ 69.672 Millions	$ 15.099 Millions

Date modified: 2026-11-08T19:29:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.